25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyze Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd together

I guess you are interested in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

1. Quick Overview

1.1. Quick analysis of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥2.26
Expected worth in 1 year
¥2.55
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.58
Return On Investment
7.1%

For what price can you sell your share?

Current Price per Share
¥8.16
Expected price per share
¥6.8791 - ¥9.66
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥8.16
Intrinsic Value Per Share
¥-0.82 - ¥0.58
Total Value Per Share
¥1.44 - ¥2.85

2.2. Growth of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (5 min.)




Is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$323.8m$309.3m$14.4m4.5%

How much money is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$14.9m$18.9m-$4m-27.0%
Net Profit Margin12.8%13.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd?

Welcome investor! Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

First you should know what it really means to hold a share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is ¥8.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.26. Based on the TTM, the Book Value Change Per Share is ¥0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%0.020.2%0.020.3%0.020.3%
Usd Book Value Change Per Share0.010.1%0.010.1%0.010.2%0.030.4%0.020.3%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.020.2%0.020.2%0.020.3%0.040.5%0.030.4%
Usd Price Per Share1.27-1.27-1.15-1.34-0.67-
Price to Earnings Ratio88.62-88.62-62.26-64.77-32.38-
Price-to-Total Gains Ratio63.74-63.74-51.29-63.19-63.19-
Price to Book Ratio4.08-4.08-3.81-4.63-2.31-
Price-to-Total Gains Ratio63.74-63.74-51.29-63.19-63.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.120368
Number of shares892
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.020.04
Gains per Quarter (892 shares)17.7437.32
Gains per Year (892 shares)70.94149.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
136356133116139
2727013266232288
3107106203100348437
4143141274133464586
5179176345166581735
6215211416199697884
72502464872328131033
82862815582659291182
932231762929910451331
1035835270033211611480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.04.00.077.8%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%16.02.00.088.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%10.00.08.055.6%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.01.00.094.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0720.0720%0.094-23%0.237-70%0.161-55%
Book Value Per Share--2.2612.2610%2.190+3%1.918+18%1.414+60%
Current Ratio--3.7023.7020%3.073+20%3.431+8%3.205+16%
Debt To Asset Ratio--0.1800.1800%0.243-26%0.247-27%0.243-26%
Debt To Equity Ratio--0.2200.2200%0.320-31%0.347-37%0.337-35%
Dividend Per Share--0.0730.0730%0.069+6%0.068+8%0.050+46%
Enterprise Value--9108765861.0009108765861.0000%9158466747.000-1%12906830598.603-29%12906830598.603-29%
Eps--0.1040.1040%0.134-22%0.171-39%0.152-31%
Ev To Ebitda Ratio--infinfnan%46.987+inf%infnan%infnan%
Ev To Sales Ratio--10.70710.7070%8.882+21%13.663-22%13.663-22%
Free Cash Flow Per Share---0.027-0.0270%0.076-135%0.102-126%0.085-132%
Free Cash Flow To Equity Per Share---0.027-0.0270%0.087-131%0.181-115%0.123-122%
Gross Profit Margin--1.0001.0000%-3.019+402%-1.351+235%-1.456+246%
Intrinsic Value_10Y_max--0.585--------
Intrinsic Value_10Y_min---0.819--------
Intrinsic Value_1Y_max--0.093--------
Intrinsic Value_1Y_min--0.027--------
Intrinsic Value_3Y_max--0.253--------
Intrinsic Value_3Y_min---0.012--------
Intrinsic Value_5Y_max--0.382--------
Intrinsic Value_5Y_min---0.155--------
Market Cap5736480000.000-68%9626890000.0009626890000.0000%8592150000.000+12%10011430435.082-4%5005715217.541+92%
Net Profit Margin--0.1280.1280%0.134-5%0.173-26%0.192-33%
Operating Margin----0%0.129-100%0.154-100%0.200-100%
Operating Ratio--0.9300.9300%0.880+6%0.841+11%0.818+14%
Pb Ratio3.609-13%4.0824.0820%3.814+7%4.628-12%2.314+76%
Pe Ratio78.349-13%88.62388.6230%62.263+42%64.768+37%32.384+174%
Price Per Share8.160-13%9.2309.2300%8.350+11%9.794-6%4.897+88%
Price To Free Cash Flow Ratio-304.479+12%-344.405-344.4050%110.206-413%21.429-1707%10.715-3314%
Price To Total Gains Ratio56.348-13%63.73763.7370%51.293+24%63.191+1%63.191+1%
Quick Ratio--0.8840.8840%2.716-67%2.589-66%2.324-62%
Return On Assets--0.0380.0380%0.046-19%0.074-49%0.093-60%
Return On Equity--0.0460.0460%0.061-25%0.106-57%0.129-64%
Total Gains Per Share--0.1450.1450%0.163-11%0.305-52%0.211-31%
Usd Book Value--323830750.426323830750.4260%309339832.042+5%267537635.369+21%191449632.355+69%
Usd Book Value Change Per Share--0.0100.0100%0.013-23%0.033-70%0.022-55%
Usd Book Value Per Share--0.3100.3100%0.301+3%0.263+18%0.194+60%
Usd Dividend Per Share--0.0100.0100%0.009+6%0.009+8%0.007+46%
Usd Enterprise Value--1250633552.7151250633552.7150%1257457484.363-1%1772107841.188-29%1772107841.188-29%
Usd Eps--0.0140.0140%0.018-22%0.023-39%0.021-31%
Usd Free Cash Flow---3837842.277-3837842.2770%10704499.488-136%13681543.562-128%11120055.801-135%
Usd Free Cash Flow Per Share---0.004-0.0040%0.010-135%0.014-126%0.012-132%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%0.012-131%0.025-115%0.017-122%
Usd Market Cap787618704.000-68%1321771997.0001321771997.0000%1179702195.000+12%1374569398.737-4%687284699.368+92%
Usd Price Per Share1.120-13%1.2671.2670%1.146+11%1.345-6%0.672+88%
Usd Profit--14914537.62614914537.6260%18947001.555-21%23394299.558-36%20085603.119-26%
Usd Revenue--116805670.008116805670.0080%141578245.757-17%134150436.856-13%107034310.198+9%
Usd Total Gains Per Share--0.0200.0200%0.022-11%0.042-52%0.029-31%
 EOD+3 -5MRQTTM+0 -0YOY+16 -245Y+13 -2610Y+15 -24

3.3 Fundamental Score

Let's check the fundamental score of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1578.349
Price to Book Ratio (EOD)Between0-13.609
Net Profit Margin (MRQ)Greater than00.128
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.884
Current Ratio (MRQ)Greater than13.702
Debt to Asset Ratio (MRQ)Less than10.180
Debt to Equity Ratio (MRQ)Less than10.220
Return on Equity (MRQ)Greater than0.150.046
Return on Assets (MRQ)Greater than0.050.038
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose8.020
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for tumors; Trop2-BB05 ADC that is in Phase I clinical trial for tumors; DLL3-BB05 ADC that has obtained phase I clinical trial approval for tumors; and HER2 ADC that has carried out phase I clinical study for tumors. The company also provides photodynamic technical platform drugs, such as hemoporfin for port wine stain, which is in Phase IV clinical trial; and aminlevulinic acid hydrochloride, which is in phase II clinical trials for cervical diseases infected by HPV, acne, and actinic keratosis. In addition, it offers nano technical platform drugs, such as Doxorubicin liposome for tumors. Further, the company offers oral solid preparation technology, which includes obeticholic acid for hepatobiliary and autoimmune disease; FZJ-003 oral preparation, which is in Phase I clinical trials for rheumatoid arthritis, as well as in Phase II clinical trials for atopic dermatitis and ulcerative colitis; and didopa controlled- release tablets, which has completed phase II clinical trial for early parkinson's disease. Additionally, it develops pharmaceutical and medical devices; medical diagnostic products and related services; and sells daily necessities, and clinical laboratory analysis instruments and software. It also engages in the technology development, transfer, consulting, and promotion activities; produces freeze-dried powder injections and APIs; and invests in overseas medical projects. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.

Fundamental data was last updated by Penke on 2025-02-15 01:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.8% means that ¥0.13 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 12.8%. The company is making a huge profit. +2
  • The TTM is 12.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.8%TTM12.8%0.0%
TTM12.8%YOY13.4%-0.6%
TTM12.8%5Y17.3%-4.6%
5Y17.3%10Y19.2%-1.8%
4.3.1.2. Return on Assets

Shows how efficient Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.8% Return on Assets means that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 3.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%0.0%
TTM3.8%YOY4.6%-0.9%
TTM3.8%5Y7.4%-3.7%
5Y7.4%10Y9.3%-1.9%
4.3.1.3. Return on Equity

Shows how efficient Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.6% Return on Equity means Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd generated ¥0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 4.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.6%TTM4.6%0.0%
TTM4.6%YOY6.1%-1.5%
TTM4.6%5Y10.6%-6.0%
5Y10.6%10Y12.9%-2.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is operating .

  • Measures how much profit Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY12.9%-12.9%
TTM-5Y15.4%-15.4%
5Y15.4%10Y20.0%-4.7%
4.3.2.2. Operating Ratio

Measures how efficient Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ¥0.93 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.930. The company is less efficient in keeping operating costs low.
  • The TTM is 0.930. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.930TTM0.9300.000
TTM0.930YOY0.880+0.050
TTM0.9305Y0.841+0.089
5Y0.84110Y0.818+0.023
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.70 means the company has ¥3.70 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 3.702. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.702. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.702TTM3.7020.000
TTM3.702YOY3.073+0.629
TTM3.7025Y3.431+0.271
5Y3.43110Y3.205+0.226
4.4.3.2. Quick Ratio

Measures if Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.88 means the company can pay off ¥0.88 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.884. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.884. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.884TTM0.8840.000
TTM0.884YOY2.716-1.833
TTM0.8845Y2.589-1.705
5Y2.58910Y2.324+0.265
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.18 means that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd assets are financed with 18.0% credit (debt) and the remaining percentage (100% - 18.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.180. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.180. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.180TTM0.1800.000
TTM0.180YOY0.243-0.063
TTM0.1805Y0.247-0.067
5Y0.24710Y0.243+0.005
4.5.4.2. Debt to Equity Ratio

Measures if Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 22.0% means that company has ¥0.22 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.220. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.220. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.220TTM0.2200.000
TTM0.220YOY0.320-0.101
TTM0.2205Y0.347-0.127
5Y0.34710Y0.337+0.010
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 88.62 means the investor is paying ¥88.62 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The EOD is 78.349. Based on the earnings, the company is expensive. -2
  • The MRQ is 88.623. Based on the earnings, the company is expensive. -2
  • The TTM is 88.623. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD78.349MRQ88.623-10.274
MRQ88.623TTM88.6230.000
TTM88.623YOY62.263+26.360
TTM88.6235Y64.768+23.855
5Y64.76810Y32.384+32.384
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The EOD is -304.479. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -344.405. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -344.405. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-304.479MRQ-344.405+39.926
MRQ-344.405TTM-344.4050.000
TTM-344.405YOY110.206-454.611
TTM-344.4055Y21.429-365.834
5Y21.42910Y10.715+10.715
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

  • The EOD is 3.609. Based on the equity, the company is fair priced.
  • The MRQ is 4.082. Based on the equity, the company is fair priced.
  • The TTM is 4.082. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.609MRQ4.082-0.473
MRQ4.082TTM4.0820.000
TTM4.082YOY3.814+0.268
TTM4.0825Y4.628-0.546
5Y4.62810Y2.314+2.314
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,876,688
Total Liabilities518,124
Total Stockholder Equity2,357,554
 As reported
Total Liabilities 518,124
Total Stockholder Equity+ 2,357,554
Total Assets = 2,876,688

Assets

Total Assets2,876,688
Total Current Assets1,869,425
Long-term Assets1,007,263
Total Current Assets
Cash And Cash Equivalents 1,195,896
Net Receivables 446,223
Inventory 43,651
Total Current Assets  (as reported)1,869,425
Total Current Assets  (calculated)1,685,770
+/- 183,654
Long-term Assets
Property Plant Equipment 520,224
Intangible Assets 86,350
Long-term Assets  (as reported)1,007,263
Long-term Assets  (calculated)606,574
+/- 400,688

Liabilities & Shareholders' Equity

Total Current Liabilities505,019
Long-term Liabilities13,105
Total Stockholder Equity2,357,554
Total Current Liabilities
Accounts payable 8,055
Total Current Liabilities  (as reported)505,019
Total Current Liabilities  (calculated)8,055
+/- 496,964
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt17,282
Long-term Liabilities  (as reported)13,105
Long-term Liabilities  (calculated)17,282
+/- 4,176
Total Stockholder Equity
Retained Earnings 918,312
Total Stockholder Equity (as reported)2,357,554
Total Stockholder Equity (calculated)918,312
+/- 1,439,242
Other
Capital Stock103,657
Common Stock Shares Outstanding 1,043,000
Net Invested Capital 2,357,554
Net Working Capital 1,364,406
Property Plant and Equipment Gross 899,771



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
142,905
145,017
130,377
158,452
298,831
304,154
358,881
537,296
749,216
824,481
1,020,265
1,120,753
1,145,134
1,459,363
1,564,825
2,500,701
2,781,172
2,976,007
2,876,688
2,876,6882,976,0072,781,1722,500,7011,564,8251,459,3631,145,1341,120,7531,020,265824,481749,216537,296358,881304,154298,831158,452130,377145,017142,905
   > Total Current Assets 
62,128
60,242
51,725
73,140
144,386
179,572
203,824
265,281
429,711
479,455
629,348
708,049
707,906
1,020,147
1,138,239
2,026,574
1,927,946
2,069,189
1,869,425
1,869,4252,069,1891,927,9462,026,5741,138,2391,020,147707,906708,049629,348479,455429,711265,281203,824179,572144,38673,14051,72560,24262,128
       Cash And Cash Equivalents 
49,755
44,180
26,280
49,351
86,898
90,305
110,069
158,267
324,927
356,097
445,997
511,284
468,144
588,221
576,799
1,396,890
1,208,881
1,289,303
1,195,896
1,195,8961,289,3031,208,8811,396,890576,799588,221468,144511,284445,997356,097324,927158,267110,06990,30586,89849,35126,28044,18049,755
       Short-term Investments 
475
38
0
0
0
143
11
0
0
0
0
0
0
0
0
0
0
33,321
0
033,32100000000001114300038475
       Net Receivables 
0
0
6,791
11,616
0
0
0
0
0
0
0
0
0
0
377,007
458,921
554,359
506,384
446,223
446,223506,384554,359458,921377,007000000000011,6166,79100
       Inventory 
1,963
2,927
8,654
12,173
14,625
15,735
7,601
6,943
15,568
13,983
9,958
23,663
39,667
32,038
31,869
36,009
35,625
40,527
43,651
43,65140,52735,62536,00931,86932,03839,66723,6639,95813,98315,5686,9437,60115,73514,62512,1738,6542,9271,963
       Other Current Assets 
9,935
13,097
10,000
0
42,863
73,389
86,143
100,071
89,216
109,375
173,393
173,102
200,095
399,888
310
0
683,440
33,321
0
033,321683,4400310399,888200,095173,102173,393109,37589,216100,07186,14373,38942,863010,00013,0979,935
   > Long-term Assets 
80,777
84,775
78,652
85,312
154,445
124,582
155,057
272,015
319,505
345,026
390,917
412,704
437,228
439,216
426,585
474,127
853,226
906,818
1,007,263
1,007,263906,818853,226474,127426,585439,216437,228412,704390,917345,026319,505272,015155,057124,582154,44585,31278,65284,77580,777
       Property Plant Equipment 
51,565
56,051
67,053
71,627
74,334
119,301
146,888
255,393
298,072
318,290
328,761
335,201
344,816
326,716
262,480
255,737
321,567
409,135
520,224
520,224409,135321,567255,737262,480326,716344,816335,201328,761318,290298,072255,393146,888119,30174,33471,62767,05356,05151,565
       Goodwill 
0
0
0
0
0
0
0
0
0
0
8,937
8,937
4,937
0
0
0
0
0
0
0000004,9378,9378,9370000000000
       Intangible Assets 
0
0
1,011
246
110
95
77
1,645
2,099
2,867
10,373
9,736
13,927
11,989
75,431
86,854
116,473
97,147
86,350
86,35097,147116,47386,85475,43111,98913,9279,73610,3732,8672,0991,64577951102461,01100
       Long-term Assets Other 
21,846
20,642
4,784
6,262
76,145
4,131
5,857
10,613
12,951
20,142
37,660
53,897
68,556
69,313
30,493
68,562
335,962
314,632
0
0314,632335,96268,56230,49369,31368,55653,89737,66020,14212,95110,6135,8574,13176,1456,2624,78420,64221,846
> Total Liabilities 
19,178
43,320
59,336
82,569
130,463
135,449
157,814
277,183
183,291
148,062
254,425
247,699
252,652
466,079
631,676
492,211
591,582
722,986
518,124
518,124722,986591,582492,211631,676466,079252,652247,699254,425148,062183,291277,183157,814135,449130,46382,56959,33643,32019,178
   > Total Current Liabilities 
19,178
12,320
18,336
51,569
72,015
118,789
88,299
223,111
122,644
121,108
235,048
231,602
239,329
454,720
571,350
427,926
528,196
673,344
505,019
505,019673,344528,196427,926571,350454,720239,329231,602235,048121,108122,644223,11188,299118,78972,01551,56918,33612,32019,178
       Short-term Debt 
0
0
1,650
21,650
20,320
56,320
28,310
86,498
15,000
25,000
125,000
120,000
140,000
150,000
152,975
6,093
8,676
109,216
0
0109,2168,6766,093152,975150,000140,000120,000125,00025,00015,00086,49828,31056,32020,32021,6501,65000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,943
0
0
101,000
0
0101,00000148,94300000000000000
       Accounts payable 
2,144
602
1,117
1,177
1,342
2,645
5,357
43,827
8,843
2,789
4,275
4,398
5,521
4,777
6,828
5,268
8,166
7,431
8,055
8,0557,4318,1665,2686,8284,7775,5214,3984,2752,7898,84343,8275,3572,6451,3421,1771,1176022,144
       Other Current Liabilities 
17,034
11,718
11,711
21,279
50,353
59,824
48,196
87,074
89,824
86,251
93,405
96,562
82,573
258,218
411,547
416,565
511,354
556,697
0
0556,697511,354416,565411,547258,21882,57396,56293,40586,25189,82487,07448,19659,82450,35321,27911,71111,71817,034
   > Long-term Liabilities 
0
31,000
41,000
31,000
58,448
16,660
69,515
54,072
60,647
26,954
19,377
16,097
13,323
11,359
60,327
64,285
63,386
49,642
13,105
13,10549,64263,38664,28560,32711,35913,32316,09719,37726,95460,64754,07269,51516,66058,44831,00041,00031,0000
> Total Stockholder Equity
120,564
99,608
70,058
73,587
135,689
139,243
170,062
223,228
532,717
650,975
732,630
843,554
872,390
982,071
931,525
2,010,931
2,192,946
2,257,102
2,357,554
2,357,5542,257,1022,192,9462,010,931931,525982,071872,390843,554732,630650,975532,717223,228170,062139,243135,68973,58770,05899,608120,564
   Common Stock
0
0
71,000
71,000
71,000
71,000
71,000
71,000
92,300
92,300
92,300
92,300
92,300
92,300
92,300
104,300
104,300
102,900
0
0102,900104,300104,30092,30092,30092,30092,30092,30092,30092,30071,00071,00071,00071,00071,00071,00000
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 
0
0
117,843
144,774
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000144,774117,84300
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
120,564
99,608
0
0
64,689
68,243
214,062
217,659
428,379
439,220
452,891
458,349
458,048
483,290
269,996
1,251,499
1,272,369
1,271,958
0
01,271,9581,272,3691,251,499269,996483,290458,048458,349452,891439,220428,379217,659214,06268,24364,6890099,608120,564



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue850,733
Cost of Revenue-70,628
Gross Profit780,105780,105
 
Operating Income (+$)
Gross Profit780,105
Operating Expense-720,770
Operating Income129,96459,336
 
Operating Expense (+$)
Research Development243,763
Selling General Administrative271,641
Selling And Marketing Expenses0
Operating Expense720,770515,404
 
Net Interest Income (+$)
Interest Income7,972
Interest Expense-3,066
Other Finance Cost-123
Net Interest Income4,783
 
Pretax Income (+$)
Operating Income129,964
Net Interest Income4,783
Other Non-Operating Income Expenses0
Income Before Tax (EBT)97,528129,964
EBIT - interestExpense = -3,066
108,627
111,694
Interest Expense3,066
Earnings Before Interest and Taxes (EBIT)0100,594
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax97,528
Tax Provision--10,922
Net Income From Continuing Ops108,450108,450
Net Income108,627
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-4,783
 

Technical Analysis of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. The general trend of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.85 < 8.86 < 9.66.

The bearish price targets are: 7.55 > 7.01 > 6.8791.

Tweet this
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. The current adx is .

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Williams %R ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose8.020
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.

Receive notifications about Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.